Form 8-K OCULAR THERAPEUTIX, INC For: Apr 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Ocular Therapeutix (OCUL) Appoints Pravin U. Dugel as CEO
April 18, 2024 4:18 PM EDTOn April 14, 2024, the board of directors of Ocular Therapeutix (NASDAQ: OCUL) appointed Pravin U. Dugel, M.D., to serve as President and Chief Executive Officer of the Company. Dr. Dugel will continue to serve as Executive Chairman and as a Class III director of the Company.
... More